O[C@@H]1CN([C:7]([O:9][C:10]([CH3:13])([CH3:12])[CH3:11])=[O:8])[C@H](C(OC)=O)C1.CC1SC(N)=NC=1.[F:25][C@H:26]1[CH2:30][NH:29][C@H:28]([C:31]([NH:33][C:34]2[CH:39]=[N:38][CH:37]=[CH:36][N:35]=2)=[O:32])[CH2:27]1>>[F:25][C@H:26]1[CH2:30][N:29]([C:7]([O:9][C:10]([CH3:13])([CH3:12])[CH3:11])=[O:8])[C@H:28]([C:31](=[O:32])[NH:33][C:34]2[CH:39]=[N:38][CH:37]=[CH:36][N:35]=2)[CH2:27]1(2S,4S)-4-Hydroxy-N-(5-methylthiazol-2-yl)pyrrolidine-2-carboxamide 65A was prepared from (2S,4S)-1-tert-butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate and 5-methylthiazol-2-amine as described for 65B. LC/MS [M+H]+: 228; Ret time (Method F): 0.55 min.
読み込み中…